N-acetyl-L-cysteine (NAC) is an antioxidant precursor of intracellular glutathione (GSH) [1] which is usually given in man as a mucolytic agent. Due to its ability to decrease HIV replication [2] and to restore intra-and extracellular GSH levels, NAC has been recently proposed as an anti-HIV agent [2]. In vitro, NAC and GSH have been shown to act on T cells by increasing IL-2 production, synthesis and turnover of IL-2 receptors, proliferation [3, 4] ‚ cytotoxic properties [5] and resistance to apoptosis [4]. NAC and some other thiol antioxidants have also been reported to regulate the activation of some transcription factors involved in IL-2 production, such as NF-κB and activator protein-1 transcription factors [6]. In view of the effects of NAC on T cells, we have evaluated whether NAC could selectively regulate Thl-or Th2-derived cytokine production. We have observed that NAC and GSH dose dependently decrease human IL-4 production by PMA plus ionomycin-stimulated peripheral blood T cells and by Con A or anti-CD3 mAbstimulated ThO-and Th2-like T cell clones. This effect (ranging from 0.5 to 20 mM) was also associated to a decrease of IL-4 mRNA transcription. In contrast, NAC and GSH have no effect on IFN-γ production but increase IL-2 production as well as T cell proliferation. One can speculate that thiols may affect the activation of transcription factors belonging to the NF-κB family and implicated in the transcription of IL-4 (such as NEAT) [7]. A key function of IL-4 is its ability to induce immunoglobulin (Ig)E and IgG4 production by human B cells [8]. This production requires a second primary signal given by triggering CD40 (by an anti-CD40 mAb or by CD40 ligand) [9] and is tightly controlled by the interaction of the cell surface 
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